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Abstract
Biologists rely on morphology, function and speciﬁc markers to deﬁne the differentiation status of cells.
Transcript proﬁling has expanded the repertoire of these markers by providing the snapshot of cellular
status that reﬂects the activity of all genes. However, such data have been used only to assess relative simi-
larities and differences of these cells. Here we show that principal component analysis of global gene
expression proﬁles map cells in multidimensional transcript proﬁle space and the positions of differentiat-
ing cells progress in a stepwise manner along trajectories starting from undifferentiated embryonic stem
(ES) cells located in the apex. We present three ‘cell lineage trajectories’, which represent the differen-
tiation of ES cells into the ﬁrst three lineages in mammalian development: primitive endoderm, tropho-
blast and primitive ectoderm/neural ectoderm. The positions of the cells along these trajectories seem
to reﬂect the developmental potency of cells and can be used as a scale for the potential of cells.
Indeed, we show that embryonic germ cells and induced pluripotent cells are mapped near the origin
of the trajectories, whereas mouse embryo ﬁbroblast and ﬁbroblast cell lines are mapped near the far
end of the trajectories. We suggest that this method can be used as the non-operational semi-quantitative
deﬁnition of cell differentiation status and developmental potency. Furthermore, the global expression
proﬁles of cell lineages provide a framework for the future study of in vitro and in vivo cell differentiation.
Keywords: embryonic stem; embryonic germ; induced pluripotent stem; mouse embryo ﬁbroblast; embryonal
carcinoma; retinoic acids; neural stem/progenitor; trophoblast stem; principal component analysis; leukemia
inhibitory factor; epigenetic landscape; Waddington; developmental potency; cell lineage trajectory; gene
expression proﬁling; DNA microarray analysis
1. Introduction
Developmental biologists have long held a view that
development naturally progresses from totipotent
fertilized eggs with unlimited differentiation potential
to terminally differentiated cells, like a ball rolling
from high to low points on a slope as depicted in
Waddington’s epigenetic landscape.
1 The epigenetic
landscape also points to another important aspect
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cell lineages during the development; cells in speciﬁc
developmental lineages are thought to take discrete
paths (‘chreodes’) on the imaginary slope. Analogy
of cell’s developmental potency to the potential
energy is thus widely accepted
2,3 This analogy is also
relevant to the fact that converting differentiated
cells into pluripotent cells is difﬁcult. In mammals,
nuclear transplantation (cloning)
4,5 had been the
only way to achieve such a ‘up-hill battle’ reprogram-
ming, until the successful production of induced
pluripotent stem (iPS) cells by infecting MEFs with ret-
roviruses carrying expression cassettes for four genes
(Myc, Pou5f1, Sox2 and Klf4).
6 Notwithsanding its
importance, the potency has only been deﬁned oper-
ationally by in vitro and in vivo cell differentiation
assays as ‘the total of all fates of a cell or tissue
region which can be achieved by any environmental
manipulation’.
7 Nuclear transplantation experiments,
where the success rate gradually decreases according
to developmental stages of donor cells, provide yet
another operational deﬁnition of developmental
potential.
8–10 We previously showed a possibility to
derive a scale of developmental potency from the
global gene expression (transcript) proﬁle data, but
the data could not be that quantitative because of
the use of a limited number of expressed sequence
tags (ESTs) for the analysis.
11 The work also did not
address the issue of cell linege separations.
Mouse embryonic stem (ES) cells
12,13 and embryo-
nic germ (EG) cells
14,15 are prototypical stem cells.
These cells can be maintained as undifferentiated
state in culture (self-renewal) and have the capacity
to differentiate into essentially all the cell types (plur-
ipotency). Therefore, these pluripotent stem cells
provide tractable systems to study the developmental
potency and cell lineage separation. It has been
shown that the manipulation of cell culture condition
or a single-gene expression level can differentiate ES
cells into relatively homogenous cell population that
are similar to the ﬁrst three lineages in mammalian
development:
16 primitive ectoderm/neural ecto-
derm,
17,18 trophoblast
19,20 and primitive endo-
derm.
21 In the ﬁrst system, ES cells are cultured in
monolayer in N2B27 medium, which drives undiffer-
entiated ES cells into neural lineages.
17 Previous DNA
microarray analysis indicates that this in vitro ES
cell differentiation process mimics in vivo cell
differentiation to primitive ectoderm, neural ecto-
derm and subsequently neurons/glia cells.
18 In the
second system, ES cells are engineered to downregu-
late Pou5f1 (Oct3/4, Oct4) expression in a tetra-
cycline-controllable manner (ZHBTc4 cell line
19). It
has been shown that repression of Pou5f1 induces
the differentiation of ES cells into trophoblast
lineage.
19,20 In the third system, ES cells that are
engineered to overexpress Gata6 in a dexametha-
sone-inducible manner differentiate into primitive
endoderm (extraembryonic endoderm).
21 Although
the analyses of these ES cell differentiation systems
have revealed the detailed changes of gene expression
patterns, it remains to see whether the global com-
parison among these individual systems provide any
further insights into developmental potency and cell
lineage separation.
Here we show that principal component analysis
(PCA), which can reduce the dimensionality of the
gene expression proﬁles,
22 maps cells in a multidi-
mensional transcript proﬁle space where the positions
of differentiating cells progress in a stepwise manner
along trajectories starting from undifferentiated ES
cells located in the apex to the ﬁrst three lineages in
mammalian development: primitive endoderm, tro-
phoblast and primitive ectoderm/neural ectoderm.
Furthermore, EG cells and iPS cells are mapped near
the origin of the trajectories, whereas mouse
embryo ﬁbroblast (MEF) and ﬁbroblast cell lines are
mapped near the far end of the trajectories.
2. Materials and methods
2.1 Cells and RNAs
For the majority of cells used in this study, we used a
stock of Cy3-labeled cRNA samples that were used in
our previous studies. The details of each cell types,
their culture conditions, RNA extractions and Cy3-
labeling can be found in the main text of this
manuscript and in earlier publications.
18,20,23–25
Cells cultured for this study and the culture conditions
are as follows. G0–G5 cells: Production and character-
ization of 5G6GR ES cell clones that are engineered to
overexpress Gata6 in a dexamethasone-inducible
manner are described previously.
21 ES cells were har-
vested every 24 h (Day 0–5) during differentiation in
the presence of 100 mM dexamethasone (Sigma).
F0–F5 cells: Undifferentiated F9 EC cells (ATCC
number: CRL-1720) were treated with 100 nM all-
trans-retinoic acid (RA, Sigma) and 1 mM dibutyryl
cAMP (dbcAMP, Sigma) on adherent condition as
reported.
26 Photos of F9 EC cells during differen-
tiation are available as Supplementary Fig. S1 of the
published paper.
27 F9 cells were harvested every
24 h (Day 0–5) during the differentiation. Both iPS-
Fbxo15
6 and iPS-Nanog
28 were cultured on the STO
feeder cells as described previously. To remove the
feeder cells, the iPS cells were passaged twice on the
gelatin-coated culture dish and harvested for RNA
extraction. NIH3T3, STO, MEF_BL6 and MEF_DR4
were cultured under the standard condition and har-
vested for RNA extraction. Total RNAs isolated for this
74 K. Aiba et al. [Vol. 16,study were labeled with Cy3-dye and used for the
DNA microarray hybridization.
2.2 Microarray data analysis
DNA microarray analysis was carried out as
described previously,
18 except for the addition of ES
cell total RNAs to the Universal Mouse Reference
RNA (UMRR) and the use of a 4   44K microarray
platform. In our previous DNA microarray studies,
23
we used the Universal Mouse Reference RNA (UMRR:
Stratagene), which is a mixture of total RNAs from
11 different mouse cell lines. However, to increase
the representation of genes expressed in ES cells for
the current study, we mixed the UMRR with total
RNAs from ES cells (MC1, derived from 129S6/
SvEvTac strain) cultured in the undifferentiated con-
dition with LIF at 2:1 ratio. These UMRR plus ES
RNAs were labeled with Cy5-dye, mixed with Cy3-
labeled samples and used for DNA microarray hybrid-
ization. To maximize the uniformity of the microarray
data, all the samples, including the ones analyzed by
DNA microarray previously, were hybridized to the
same platform (the NIA Mouse 44K Microarray
v3.0
23 manufactured by Agilent Technologies
#015 087). The intensity of each gene feature per
array was extracted from scanned microarray images
using Feature Extraction 9.5.1.1 software (Agilent
Technologies) as described previously.
23 Hierarchical
clustering analysis and PCA (see Section 2.3) were
carried out using an application developed in-house
to perform ANOVA and other analyses (NIA Array
Analysis software; http://lgsun.grc.nia.nih.gov/
ANOVA/).
22 Three-dimensional PCA ﬁgures were gen-
erated using the virtual reality modeling language
(VRML) function of the NIA Array Analysis software
22
and visualized by Cortona Vrml client (http://www.
parallelgraphics.com/products/cortona/). To
produce plots and lists of genes for Fig. 2, we used
the R-statistical package
29 and only non-redundant
set of oligonucleotide probes (a total of 25 164
probes/genes). Of these, 21 890 genes were signiﬁ-
cant in ANOVA with FDR , 0.05 and used for further
analyses. Genes correlated to each cell lineage trajec-
tory were identiﬁed based on the correlation of
.0.90. All the DNA microarray data have been depos-
ited in the NCBI Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo/) and are accessible
Figure 1. Global gene expression proﬁles of 32 different cell types. Names of the cells and their abbreviated forms are shown. Color coding
corresponds with the colors in all other ﬁgures. DNA microarray analysis was carried out in duplicate: for each cell type, two independent
cell cultures were prepared and used for separate DNA microarray analysis. Reproducibility between two microarray data for each cell
type was very high as shown by the Pearson correlation coefﬁcient (mean 0.9927; SD 0.0043; range 0.9788–0.9966). The average of
two samples is shown here. (A) Hierarchical clustering analysis. (B) Principal component analysis (PCA). Individual cell types are mapped
in the 3D space according to the ﬁrst three principal components (PC1, PC2 and PC3). A movie ﬁle is available as Supplementary
Video S1.
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and the NIA Array Analysis software website (http://
lgsun.grc.nia.nih.gov/ANOVA/).
22
2.3 Principal component analysis
Principal component analysis is a statistical method
to ﬁnd major patterns in data variation, which is
increasingly used for the analysis of gene expression
microarray data.
22,30–32 Each principal component
(PC) is a linear combination of log-transformed
expression values of all genes, and all components
are orthogonal, i.e. mutually independent. The ﬁrst
few PCs, which explain most of the observed variance,
are the most important; the remaining PCs often rep-
resent random ﬂuctuations. Therefore, by plotting
data against the ﬁrst two or three PCs, one can
reduce the dimensionality of the data without losing
much of information. Contribution of genes to each
PC (which may be positive or negative) is determined
by singular value decomposition algorithm applied to
the covariance matrix. Knowing these contributions,
the entire gene expression proﬁle of a given cell type
can be represented by a single point in a two- or
three-dimensional space. If two cell types are rep-
resented by closely located points in the PCA plot,
global gene expression proﬁles of these cells are very
similar. In contrast, if corresponding points in the
PCA plot are far apart, their global expression proﬁles
are very different. The detailed discussion of PCA plots
and interpretation of DNA microarray data can be
found in the previous publication.
32
3. Results and discussion
To obtain accurate, comprehensive and comparable
expression proﬁles,wecarriedoutalltheDNA microar-
ray analyses within a few weeks using the same
platform containing essentially all genes encoded on
the mouse genome.
23 Although two ES cell differen-
tiation systems have been proﬁled previously using
the earlier version of the array platform,
18,20 we
carried out the DNA microarray analysis again for the
data consistency. In the ﬁrst system, ES cells are cul-
tured in monolayer in N2B27 medium for 6 days,
which drives undifferentiated ES cells into neural
lineages.
17 RNAs were isolated and analyzed every
day during the induction and RNAs (N0–N6: Fig. 1A).
Previous DNA microarray analysis has been carried
out using the array platform containing a limited
number of genes, but indicates that this in vitro ES
cell differentiation process mimics in vivo cell differen-
tiation to primitive ectoderm, neural ectoderm and,
subsequently, neurons/glia cells.
18 In the second
system, ES cells that are engineered to downregulate
Pou5f1 (Oct3/4, Oct4) expression in a tetracycline-
controllable manner (ZHBTc4 cell line differentiate
into trophoblast lineage for 5 days).
19,20 RNAs were
isolated and analyzed every day during the induction
(Z0–Z5 in Fig. 1A). To include the ﬁrst three lineages
of mammalian development,
16 we added a third
system: ES cells that are engineered to overexpress
Gata6inadexamethasone-inducible mannerdifferen-
tiate into primitive endoderm (extra-embryonic endo-
derm) for 5 days
21 (G0–G5 in Fig. 1A). We also carried
out microarray analysis of a fourth system: F9 embryo-
nal carcinoma (EC) cells differentiate into parietal
endoderm—one of the extra-embryonic endoderm
lineagesfor5days
26,27(F0–F5inFig.1A).Forcompari-
son,wealso analyzedP19ECcellsbefore(P0)andafter
4 days of RA induction (P4); neural stem/progenitor
(NS)cellsderivedfromadultmousebrainandtheirdif-
ferentiated cells
21 (DC); and trophoblast stem (TS)
cells
26 and E12.5 placenta (PL).
27 Altogether we
obtained the DNA microarray data of 32 different cell
types in duplicate.
Figure 2. Average expression levels of selected genes correlate well with the locations of each cell type in PCA coordinates. See Fig. 1A for
the abbreviated names of the cells. Each point shows DNA microarray data for each sample; therefore, each cell type is represented by
two points. (A) Primitive endoderm lineage, represented by the list of 1738 genes (Supplementary Table S1). (B) Trophoblast lineage,
represented by the list of 2311 genes (Supplementary Table S2). (C) Primitive ectoderm/neural lineage, represented by the list of 2463
genes (Supplementary Table S3).
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analysis of these microarray data. Although the hier-
archical clustering analysis grouped cells mostly into
each differentiation system (Fig. 1A), it showed only
the degree of similarity between different cell types
and did not provide any insights into the relationship
between the different cell lineages. To further analyze
the data, we employed PCA, which can reduce the
dimensionality of the gene expression proﬁles and
map individual cells in a multidimensional space
according to their global gene expression patterns
(see Section 2.3 for the explanation of PCA). We ﬁrst
mapped the cells in the 3D transcript proﬁle space
(PC1, PC2 and PC3) (Fig. 1B). PCA of all these micro-
array data uncovered three major paths of differen-
tiation from undifferentiated ES cells in 3D
transcript proﬁle space (Fig. 1B; Supplementary
Video S1). Each path showed progressive changes in
global expression patterns toward speciﬁc cell
lineages: trophectoderm (Z0–Z5), extra-embryonic
endoderm (G0–G5; F0–F5) and neural tissues
(N0–N6). We call these paths ‘cell lineage trajec-
tories,
32’ because the cell differentiation process can
be visualized as a trajectory in the multidimensional
transcript proﬁle space.
What do these trajectories represent? Because the
transcript proﬁle space is constructed from the
expression patterns of genes, the changes in gene
expression patterns are reﬂected in the changes in the
position of a cell. To ﬁnd gene expression changes that
are correlated with these trajectories, we ﬁrst drew a
line for each cell lineage so that the squared distances
from the cells of the lineage were minimized. The
locations of other cell types, such as TS and NS, were
projected onto the closest lineage trajectory (Fig. 1B).
The x-axis of Fig. 2 shows the coordinates of these cell
typesoneachtrajectory(Fig.2A–C).Wethensearched
for sets of genes that were positively correlated with
each trajectory line. We identiﬁed 1738 genes for the
primitive endoderm lineage (Fig. 2A; Supplementary
Table S1), 2311 genes for the trophoblast lineage
(Fig. 2B; Supplementary Table S2) and 2463 genes
for the primitive ectoderm/neural lineage (Fig. 2C;
Supplementary Table S3) with a correlation of .0.90.
Theexpressionlevelsofthesegenesgraduallyincreased
as ES cells differentiated into each lineage (see
Supplementary data for examples of gene expression
changes). The average expression levels of these genes
(y-axis in Fig. 2: cell lineage index
32) can thus be used
as surrogates for the coordinates of cell’s positions on
each trajectory (x-axis in Fig. 2). This lineage trajectory,
therefore,notonlydeﬁnesapathtothefatesofindivid-
ual cell lineages, but also provides a scale for the extent
of commitment/differentiation.
This notion was further supported by examining the
locations of cells cultured and proﬁled independently
in the transcript proﬁle space: P19 EC cells before (P0)
and after 4 days of RA induction (P4); NS cells derived
from adult mouse brain and their differentiated
cells
18 (DC); and TS cells
25,33 and E12.5 PL.
25 These
cells were mapped onto the transcript proﬁle space
based on their global gene expression proﬁles. As we
expected, we found that P0, P4, NS and DC mapped
near the primitive ectoderm/neural lineage trajectory
(Figs 1B and 2C). Interestingly, the position of P0 was
consistent with the notion that in contrast to ES cells,
undifferentiated P19 EC cells are more committed
and equivalent to primitive ectoderm cells.
18 The pos-
ition of P4 was also consistent with the notion that
P19 EC cells differentiate into neuron-like cells after
the induction with RA.
34 Consistent with their
known differentiation status, TS and PL mapped near
the trophoblast lineage trajectory (Figs 1B and 2B).
Two extra-embryonic endoderm lineages, which
were represented by F9 EC cell differentiation
26,35
(F0–F5) and ES cells driven by Gata6
21 (G0–G5),
also showed lineage trajectories close to each other
(Figs 1B and 2A). Taken together, these data support
the notion that cell differentiation can be visualized
as cell lineage trajectories in 3D transcript proﬁle
space.
We also noticed that these cell lineage trajectories
represent the gradual loss of developmental potency
or potential of cells (Fig. 1B). To examine this point
further, we carried out microarray analysis of 12
additional cell types, including three undifferentiated
ES cell lines (MC1, derived from 129S6/SvEvTac; MC2,
derived from C57BL/6J; D3_GL; and EBRTcH3) and
two undifferentiated EG cell lines [TGC8.5_5,
derived from the primordial germ cell (PGC) of E8.5
C57BL/6J embryo; and EG1, derived from the PGC
of E9 129 embryo].
24 We also analyzed the expression
proﬁles of MEF cells, stromal cells (STO) and a ﬁbro-
blast cell line (NIH3T3). We then analyzed iPS cells,
which have been established by infecting MEFs with
retroviruses carrying expression cassettes for four
genes (Myc, Pou5f1, Sox2 and Klf4).
6,28 We used two
different iPS lines: one was established by using
Fbxo15 promoter-driven GFP as an indicator of
pluripotency
6 and the other was established by
using Nanog promoter-GFP as an indicator of
pluripotency.
28
Hierarchical clustering analysis of the microarray
data of all 44 cell types (original 32 cell types and
12 additional cell types; see Supplementary data for
detail) showed that undifferentiated ES and EG cells
were clustered together with iPS cells, whereas
NIH3T3 ﬁbroblast cells, STO stromal cells and MEF
cells were clustered together (Fig. 3A). However, it
was difﬁcult to assess the overall relationship among
all the cell types analyzed here. We, therefore, ana-
lyzed the microarray data of all 44 cell types by PCA
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overall structure of the transcript proﬁle space
remained essentially the same as that obtained by
32 cell types (Fig. 1B). The majority of the cells were
aligned along the three major cell lineage trajectories,
except for ﬁbroblast and stromal cells (NIH3T3, STO
and MEFs). The fact that these cells did not fall into
any of the three cell lineage trajectories is consistent
with their mesodermal origin. Their locations near
the bottom of all three trajectory lines also support
the general trend that these cell lineage trajectories
represent the gradual loss of developmental potency
of cells (Fig. 1B). Indeed, undifferentiated ES and EG
cells mapped near the apex of the trajectory ﬁgures,
as expected (Fig. 3B). Similarly, the iPS cells mapped
near the apex of the trajectories. It has been demon-
strated that these iPS cells have the complete
phenotype of pluripotent cells, including germline
competency in the case of iPS-Nanog.
28 Considering
that the iPS cells are derived from MEFs, changing
the locations of cells from positions with low develop-
mental potency (MEFs) to those with high develop-
mental potency (iPSs) strongly supports our notion
that PCA analysis can visualize and predict the devel-
opmental potency of cells.
The work presented here provides a concept and a
method to visualize and quantitate the differentiation
status and developmental potency of cells. The PCA
ﬁgures (Figs 1B and 3B) show remarkable similarity
to the conceptual picture of Waddington’s epigenetic
landscape, where cell lineage trajectories represent
creodes.
1 Such a concept has been taken for granted
by embryologists for over a century, but it now
seems to be substantiated by the global gene
expression patterns. The locations of cells in the multi-
dimensional transcript proﬁle space can be used to
Figure 3. Global gene expression proﬁles of 44 different cell types. In addition to 32 cell types in the Fig. 1, 12 cell types are added for the
analysis. Names of the cells and their abbreviated forms are shown. Color coding of cells are consistent throughout the paper. Average of
two samples is shown. (A) Hierarchical clustering analysis. (B) Principal component analysis (PCA). Individual cell types are mapped in
the 3D space according to the ﬁrst three principal components (PC1, PC2 and PC3). A movie ﬁle is available Supplementary Video S2.
78 K. Aiba et al. [Vol. 16,identify cells of unknown origin, determine the
differentiation status of cells and to assess the devel-
opmental potency of cells, possibly without going
through experimental manipulation and testing of
the cells. The present work also provides a framework
for the future study of ES cell differentiation by visua-
lizing the direction to which cells are going to
differentiate.
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